Navigation Links
Beaumont Doctor's Invention Improves Cataract Surgery Outcomes

ROYAL OAK, Mich., Aug. 26 /PRNewswire/ -- The Beaumont Commercialization Center, a medical technology development company within Beaumont Hospitals, is making an innovative ophthalmic lens support system available for licensing.

Timothy Page, M.D., a Beaumont ophthalmologist, developed the advanced lens support system to stabilize the lens before or during cataract surgery, thereby preventing the movement of lens fragments into the back of the eye.

Each year, approximately 10 million people worldwide have cataract surgery. Elements of the eye, such as vitreous body or the lens capsule, can shift as the cataract is removed. Vitreous body, a clear gel that fills the eyeball behind the lens, can move into the front of the eye when the lens is not fully supported. This movement can lead to complications such as capsule tears, zonular dialysis, and dislocation of the lens into the back of the eye, requiring the patient to have an additional surgery by a retina specialist.

"I am excited to be able to bring something like this to market," said Dr. Page, who has been in practice for 14 years. "The system is an important development in minimizing risks and complications that can occur in such a common procedure." Dr. Page has offices in Troy and Birmingham, Michigan.

Other techniques with various apparatus do exist, such as the use of a net or levitation using the tip of a probe. They are not ideal for various reasons. A net can block the needed removal of lens fragments while the extremely small diameter of a probe makes it a challenge for even experienced surgeons to balance and elevate lens fragments.

This new lens support system consists of a cannula and a piston. By means of the piston, the lens support is movable to contracted and expanded configurations.

For licensing information, contact Mike Tanner, Director of Technology Development, at (248) 551-0567 or email him at .

For additional information on this and other licensing opportunities from the Beaumont Commercialization Center, please visit .

About the Beaumont Commercialization Center

Part of Beaumont Hospitals, headquartered in Royal Oak, MI, the Beaumont Commercialization Center is a hospital-based medical device development resource focused on helping manufacturers and inventors bring their ideas for new medical devices and technology to reality. The full-service center blends product development knowledge with the experience of physicians and clinical staff at Beaumont Hospitals.

The Beaumont Commercialization Center offers intellectual property, design engineering, prototype services, usability testing, clinical trials, and regulatory assistance. For more information about the Beaumont Commercialization Center, visit .

SOURCE Beaumont Commercialization Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Beaumont Technology Usability Center To Offer Training For Medical Technology Companies
2. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
3. Beaumont Hospitals in Michigan Selects Halogen Software for Pay for Performance System
4. Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy
5. Black Enterprise Unveils Americas Leading Doctors
6. Special coating greatly improves solar cell performance
7. Method to deliver molecules within embryonic stem cells improves differentiation
8. Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability
9. Elusys Anthim(TM) Dramatically Improves Survival of Animals Treated After Active Anthrax Infection
10. Survey: 90% of Participating Surgeons Report Syndicom SpineConnect Improves Practice of Spine Surgery
11. Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium
Post Your Comments:
(Date:10/12/2015)... cell surface marker detection market ... to a new report by Grand View Research, Inc. This ... of oncology diseases and other cell-associated disorders. --> ... USD 6.49 billion by 2022, according to a new report ... be attributed to rise in incidence of oncology diseases and ...
(Date:10/12/2015)...  Patara Pharma, a clinical-stage biotechnology company developing ... conditions, today announced the closing of a $26 ... the close of its sale of preferred stock, ... Agreement with Silicon Valley Bank whereby the Company ... use the funds from the financing to evaluate ...
(Date:10/12/2015)... , Belgium , Oct. 12, 2015 /PRNewswire/ ... that full results from a completed clinical study of its ... have been published in the online issue of Clinical ... The peer-reviewed study was conducted in collaboration with ... led by Roland Andersson , MD, PhD, Professor of ...
(Date:10/12/2015)... ... ... LifeTrak , a leader in consumer fitness, heart rate and activity ... tracker that seeks to meet the needs of multi-sport athletes. Zoom is the first ... both in water and on land, making it the only fitness tracker an athlete ...
Breaking Biology Technology:
(Date:10/8/2015)... SAN JOSE, Calif. , Oct. 8, 2015 ... leading developer of human interface solutions, announced today ... first quarter of fiscal 2016 on Thursday, October ... company will host a corresponding conference call for ... p.m. ET), during which management may discuss forward-looking ...
(Date:10/8/2015)... NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that revenues for the three months ended ... $113,00 for the three months ended June 30, ... 30, 2015 were approximately $520,000.      ...
(Date:10/7/2015)... Connecticut , October 7, 2015 ... authentication company focused on the growing mobile commerce market ... Stanley E. Washington , former long- term executive ... of Directors. --> NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ...
Breaking Biology News(10 mins):